⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Ivermectin cream 1% (rosacea)
ایورمکتین کرم ۱٪ (روزاسه)
🧴 DermatologicalsTopical anti-inflammatory/antiparasitic
🤰 Pregnancy:Use with caution🤱 Breastfeeding:Use with caution👶 Children:Safety not established👴 Older adults:Use with caution 🇮🇷 Registered in Iran 🇺🇸 FDA approved (NDA) NDA206255ATC D11AX22
Market / country: 🇺🇸 USA
Soolantra (US)
🧮 Dose calculator
Rosacea · Regimen source: FDA Soolantra · 2
⛔ Once daily, a pea-sized amount for each area (forehead, chin, nose, each cheek); thin layer, away from eyes and lips. FDA Soolantra · 2
🛡️ Safety & information
Formulations
- Ivermectin 1% cream (30, 45, 60 g) — cream 🇺🇸 USA FDA Soolantra · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Soolantra · 8.1
“Risk Summary The available data on the use of ivermectin, including SOOLANTRA cream, in pregnant women are insufficient to establish a drug- associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Soolantra · 8.2
“Risk Summary The presence of ivermectin in human milk following topical administration of ivermectin has not been evaluated.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Soolantra · 8.4
“Safety and effectiveness of SOOLANTRA cream in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Soolantra · 8.5
“Of the 1371 subjects in the two pivotal clinical studies of SOOLANTRA cream, 170 (12.4%) were 65 and over, while 37 (2.7%) were 75 and over.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA206255
- DailyMed (FDA label)FDA Soolantra
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDD11AX22
- Darooyab (Iran)Ivermectin
🇮🇷 Registered in Iran Darooyab · G-239/Ivermectin
Dosage forms with Iranian generic codes, per Darooyab.
- 05962 · IVERMECTIN 3MG TAB · قرص ایورمکتین ۳ میلیگرم
- 24191 · IVERMECTIN CREAM TOPICAL 1 % 30 GRAM · کرم ایورمکتین ۱ درصد ۳۰ گرم
- 51473 · IVERMECTIN TABLET ORAL 6 mg · قرص ایورمکتین ۶ میلیگرم
- 52096 · IVERMECTIN LOTION TOPICAL 0.5 % 120 g · لوسیون ایورمکتین ۰٫۵ درصد ۱۲۰ گرم
- 50902 · IVERMECTIN CREAM TOPICAL 1 % 15 g · کرم ایورمکتین ۱ درصد ۱۵ گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Soolantra · 3FDA Soolantra · 2FDA Soolantra · 8.1FDA Soolantra · 8.2FDA Soolantra · 8.4FDA Soolantra · 8.5FDA Soolantra · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-239/Ivermectin
- Clinical review⚠ Unverified